TRUP TRUPANION, INC.
Hospital & Medical Service Plans · Nasdaq · SEC CIK 1371285 · Fiscal year ends 12/31
Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters
Growth
TTM revenue YoY11.4%
TTM net income YoY72.2%
TTM EPS YoY69.4%
Revenue 3-yr CAGR13.8%
Net income 3-yr CAGR—
Margins
Gross margin—
Operating margin1.8%
Net margin1.7%
FCF margin5.6%
EBITDA margin2.8%
Returns
ROE6.9%
ROA3.0%
ROIC (approx.)7.9%
Asset turnover1.73x
Leverage & solvency
Liabilities / assets56.7%
Debt / equity0.26x
Current ratio1.74x
Interest coverage2.90x
Cash quality & payout
Operating cash flow / net income3.59x
Accruals ratio-7.7%
Payout ratio—
Capex / revenue0.6%
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | FY2025*2025-12-31 | FY2024*2024-12-31 |
|---|---|---|
| Income statement | ||
| Revenue | $1.44B | $1.29B |
| Cost of revenue | $1.21B | $1.11B |
| SG&A expense | $76.65M | $63.73M |
| Operating income | $13.84M | -$9.51M |
| Interest expense | $13.76M | $14.50M |
| Pretax income | $21.99M | -$9.64M |
| Income tax | $2.56M | -$5,000 |
| Net income | $19.43M | -$9.63M |
| EBITDA | $29.67M | $6.95M |
| EPS (basic) | 0.45 | -0.23 |
| EPS (diluted) | 0.45 | -0.23 |
| Weighted avg. shares (diluted) | 43.56M | 42.16M |
| Balance sheet | ||
| Cash & equivalents | $138.02M | $199.53M |
| Short-term investments | $232.71M | $147.09M |
| Current assets | $691.06M | $597.33M |
| PP&E, net | $104.84M | $102.19M |
| Goodwill | $39.38M | $36.97M |
| Intangibles | $24.10M | $13.18M |
| Total assets | $915.04M | $806.85M |
| Current liabilities | $409.81M | $349.63M |
| Short-term debt | $10.00M | $1.35M |
| Long-term debt | $101.78M | $127.54M |
| Total debt | $111.78M | $128.89M |
| Total liabilities | $531.11M | $483.58M |
| Shareholders' equity | $383.94M | $323.27M |
| Net debt | -$26.24M | -$70.64M |
| Shares outstanding | 43.40M | 42.49M |
| Cash flow statement | ||
| Operating cash flow | $89.49M | $48.29M |
| Capital expenditure | $14.13M | $9.72M |
| Free cash flow | $75.36M | $38.57M |
| Investing cash flow | -$95.89M | -$13.46M |
| Financing cash flow | -$22.86M | -$3.96M |
| Depreciation & amortization | $15.84M | $16.47M |
| Stock-based compensation | $38.31M | $33.43M |
| Share buybacks | — | $0 |
Free plan shows the latest 2 periods; Pro shows all 14 🔒
· Financial companies (banks, insurers, …) usually do not report gross profit or operating income; bank revenue is net revenue (net interest income + noninterest income), smaller than "gross interest income + noninterest income".
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-21 06:27.